Literature DB >> 23777751

Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.

Yusuke Yamaguchi1, Takanori Moriki, Atsuko Igari, Yumiko Matsubara, Tomoko Ohnishi, Kazuya Hosokawa, Mitsuru Murata.   

Abstract

INTRODUCTION: A whole blood flow-chamber system, the Total Thrombus-formation Analysis System (T-TAS), was developed for quantitative analysis of platelet thrombus formation (PTF) using microchips with thrombogenic surfaces (collagen, PL chip; collagen plus tissue thromboplastin, AR chip) under shear stress conditions. We evaluated the usefulness of the T-TAS for assessing individual thrombogenicity compared with other platelet function tests.
MATERIALS AND METHODS: Blood samples from 31 healthy volunteers were applied to the T-TAS to measure PTF starting time (T10: time to reach 10 kPa), occlusion time (T60 for PL chip; T80 for AR chip), and area under the curve (AUC10, area under curve until 10 min for PL chip; AUC30, 30 min for AR chip) under various shear rates (1000, 1500, 2000s(-1) for PL chip; 300 s(-1) for AR chip). Platelet functions were also tested using platelet aggregometry, the PFA-100 (collagen and epinephrine [C/EPI], collagen and adenosine diphosphate [C/ADP]), and the VerifyNow P2Y12 assay.
RESULTS: Individual pressure waveforms, including PTF starting and ending points, varied among healthy subjects. In the PL chip, T10 and AUC10 showed a shear-dependent correlation with C/EPI or C/ADP. VerifyNow P2Y12 values were not significantly associated with the parameters of the T-TAS. Platelet counts were correlated with all AR measurements, and mostly with PL measurements.
CONCLUSION: The results of the T-TAS were associated with those of the PFA-100 in many respects, indicating that its characteristics are related to shear-induced PTF. The T-TAS showed few correlations with platelet aggregometry and the VerifyNow P2Y12 assay. The T-TAS may allow for the measurement of comprehensive parameters of individual thrombogenicity under whole blood flow conditions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Flow-chamber system; Platelet; Thrombogenicity; Thrombus formation

Mesh:

Year:  2013        PMID: 23777751     DOI: 10.1016/j.thromres.2013.05.026

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  Evaluation of the antithrombotic abilities of non-vitamin K antagonist oral anticoagulants using the Total Thrombus-formation Analysis System®.

Authors:  Yoshiaki Idemoto; Shin-Ichiro Miura; Kenji Norimatsu; Yasunori Suematsu; Yuka Hitaka; Yuhei Shiga; Joji Morii; Satoshi Imaizumi; Takashi Kuwano; Atsushi Iwata; Bo Zhang; Masahiro Ogawa; Keijiro Saku
Journal:  Heart Vessels       Date:  2016-06-21       Impact factor: 2.037

2.  Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels.

Authors:  Shahid M Nimjee; David Dornbos; George A Pitoc; Debra G Wheeler; Juliana M Layzer; Nicholas Venetos; Allyson Huttinger; Spencer E Talentino; Nicholas J Musgrave; Holly Moody; Rachel E Rempel; Cheyenne Jones; Kendyl Carlisle; Jenna Wilson; Camille Bratton; Matthew E Joseph; Shoeb Khan; Maureane R Hoffman; Laura Sommerville; Richard C Becker; Jay L Zweier; Bruce A Sullenger
Journal:  Mol Ther       Date:  2019-03-30       Impact factor: 11.454

3.  Microfluidics contrasted to thrombelastography: perplexities in defining hypercoagulability.

Authors:  Peter J Lawson; Hunter B Moore; Ernest E Moore; Mark E Gerich; Gregory R Stettler; Anirban Banerjee; Richard D Schulick; Trevor L Nydam
Journal:  J Surg Res       Date:  2018-06-08       Impact factor: 2.192

4.  Analysis of blood clotting with the total thrombus analysis system in healthy dogs.

Authors:  Tomoko Iwanaga; Ryuji Fukushima; Tomoka Nagasato; Ikuro Maruyama; Naoki Miura
Journal:  J Vet Diagn Invest       Date:  2021-02-09       Impact factor: 1.279

5.  Global/integral assays in hemostasis diagnostics: promises, successes, problems and prospects.

Authors:  Mikhail A Panteleev; Hendrik Coenraad Hemker
Journal:  Thromb J       Date:  2015-01-28

6.  Evaluation of the Antithrombotic Effects of Rivaroxaban and Apixaban Using the Total Thrombus-Formation Analysis System®: In Vitro and Ex Vivo Studies.

Authors:  Hidekazu Sugihara; Yoshiaki Idemoto; Takashi Kuwano; Yoshihisa Nagata; Joji Morii; Makoto Sugihara; Masahiro Ogawa; Shin-Ichiro Miura; Keijiro Saku
Journal:  J Clin Med Res       Date:  2016-10-26

7.  Monitoring of Antithrombotic Therapy.

Authors:  Masako Yamazaki
Journal:  J Atheroscler Thromb       Date:  2019-11-01       Impact factor: 4.928

Review 8.  Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review.

Authors:  Sagnik Sen; Naresh Babu Kannan; Jayant Kumar; Renu P Rajan; Karthik Kumar; Girish Baliga; Harshavardhan Reddy; Anubhav Upadhyay; Kim Ramasamy
Journal:  Int Ophthalmol       Date:  2021-08-11       Impact factor: 2.031

9.  Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.

Authors:  Miwa Ito; Koichi Kaikita; Daisuke Sueta; Masanobu Ishii; Yu Oimatsu; Yuichiro Arima; Satomi Iwashita; Aya Takahashi; Tadashi Hoshiyama; Hisanori Kanazawa; Kenji Sakamoto; Eiichiro Yamamoto; Kenichi Tsujita; Megumi Yamamuro; Sunao Kojima; Seiji Hokimoto; Hiroshige Yamabe; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

10.  Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study.

Authors:  Kiyoaki Yamamoto; Takashi Ito; Tomoka Nagasato; Atsushi Shinnakasu; Mihoko Kurano; Aiko Arimura; Hiroshi Arimura; Hiroshi Hashiguchi; Takahisa Deguchi; Ikuro Maruyama; Yoshihiko Nishio
Journal:  Thromb J       Date:  2019-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.